Zeldovich Alina, Ghabrial Raf
Sydney Oculoplasty Surgery, Eye Associates, Sydney, Australia.
Orbit. 2009;28(6):328-31. doi: 10.3109/01676830903104686.
To determine the success rate of revision endoscopic dacryocystorhinostomy (DCR) with an injection of intraoperative betamethasone under local anaesthetic.
In a prospective, nonrandomized consecutive case series, 16 adult patients (19 eyes) with failed primary endoscopic DCR underwent revision surgery under assisted local anaesthetic. During revision endoscopic DCR, 1mg of betamethasone was injected into the lacrimal sac and scar tissue surrounding the surgical osteum. The surgical success rate was then determined based on anatomical patency and resolution of patient symptoms.
There were 16 patients (12 female, 4 male) and 3 had bilateral surgery. Patient ages ranged from 43 to 92 (mean 67). Follow up ranged from 1 to 15 months (mean 9). Anatomical patency was achieved in 16 cases (84%) and patient symptoms had improved in 17 cases (89%). Of the two cases that continued to have symptoms 1 achieved anatomical patency and the other had not.
Revision endoscopic DCR, under assisted local anaesthetic, had a high success rate (89%) when an injection of betamethasone was administered intraoperatively.
确定在局部麻醉下注射术中倍他米松进行内镜下泪囊鼻腔造口术(DCR)翻修术的成功率。
在一项前瞻性、非随机连续病例系列研究中,16例原发性内镜下DCR失败的成年患者(19只眼)在辅助局部麻醉下接受翻修手术。在翻修内镜下DCR过程中,将1mg倍他米松注入泪囊和手术骨孔周围的瘢痕组织。然后根据解剖通畅情况和患者症状的缓解情况确定手术成功率。
16例患者(12例女性,4例男性),3例行双侧手术。患者年龄范围为43至92岁(平均67岁)。随访时间为1至15个月(平均9个月)。16例(84%)实现了解剖通畅,17例(89%)患者症状有所改善。在仍有症状的2例患者中,1例实现了解剖通畅,另1例未实现。
在辅助局部麻醉下进行内镜下DCR翻修术时,术中注射倍他米松的成功率较高(89%)。